Canada - English - Health Canada

viiv healthcare ulc - dolutegravir (dolutegravir sodium); lamivudine - tablet - 50mg; 300mg - dolutegravir (dolutegravir sodium) 50mg; lamivudine 300mg - hiv integrase inhibitors

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - dolutegravir as sodium; lamivudine - film coated tablets - lamivudine 300 mg; dolutegravir as sodium 50 mg - lamivudine and dolutegravir - dovato is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine and viral load ≤500,000 c/ml.